Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Leroy H, Gadaud N, Bérard E, Klein E, Luquet I, Vial JP, Rieu JB, Lechevalier N, Tavitian S, Leguay T, Largeaud L, Bidet A, Delabesse E, Sarry A, de Grande AC, Récher C, Pigneux A, Bertoli S, Dumas PY.
Leroy H, et al. Among authors: dumas py.
Cancer Med. 2024 Feb;13(3):e7003. doi: 10.1002/cam4.7003.
Cancer Med. 2024.
PMID: 38400682
Free PMC article.